EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Frontiers in Oncology



Status
active
Subject

Source type
Journal
Publisher
E ISSN
2234-943X
First volume
1
Last volume
14+
Publish city
Lausanne
Homepage
Description

Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, therapeutics, and management strategies.

The journal is led by Field Chief Editor Prof Giuseppe Giaccone (Cornell University and Amgen, USA), and Assistant Field Chief Editor Prof Sharon Pine (University of Colorado, USA). Indexed in PubMed Central (PMC), Scopus, Web of Science (SCIE), and the DOAJ, Frontiers in Oncology welcomes clinical and experimental research contributions in the various domains of cancer research, which bridge the gap between basic research and clinical applications. Topics include, but are not limited to:

  • breast cancer
  • cancer cell signaling
  • cancer epidemiology and prevention
  • cancer genetics
  • cancer imaging and image-directed interventions
  • cancer immunity and immunotherapy
  • cancer metabolism
  • cancer molecular targets and therapeutics
  • cardio-oncology
  • gastrointestinal cancers
  • genitourinary oncology
  • gynecological oncology
  • head and neck cancer
  • hematologic malignancies
  • molecular and cellular oncology
  • neuro-oncology and neurosurgical oncology
  • pediatric oncology
  • pharmacology of anti-cancer drugs
  • radiation oncology
  • skin cancer
  • surgical oncology
  • thoracic oncology.











Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )